Postoperative Analgesia Investigation



Status:Active, not recruiting
Conditions:Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - Any
Updated:5/6/2018
Start Date:October 2013
End Date:December 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control.

The primary objective of the study is to compare the efficacy of standard local anesthetic
bupivicaine and liposomal bupivicaine in postoperative pain control both in magnitude and
duration in patients undergoing sternotomy, thoracotomy, thoracoabdominal, and laparotomy
incisions.


Inclusion Criteria:

- 18 years-old or older, and

- Sternotomy, thoracotomy, laparotomy or thoracoabdominal incision is planned

- There is reasonable expectation that the patient will be extubated within 24 hours
after surgery

Exclusion Criteria:

- The patient has a known allergy to morphine or any opioid

- The patient has a known chronic pain disorder or takes daily opioid medication > 1
month prior to surgery

- The surgeon/anesthesiologist concludes that the period for intubation will be likely
be for more than 24 hours after surgery

- There is anticipated difficulty communicating pain status due to language or other
barriers at the investigator discretion.
We found this trial at
1
site
The University of Texas Health Science Center at Houston Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hosptial; Heart and Vascular Institute
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials